(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol, 98%, 1g

N-[4-Fluoro-3-(prop-2-enamido)phenyl]-1-(2-fluorophenyl)-1H-pyrazole-4-carboxamide, 98.0%, 50mg

N-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide, 95.0%, 5g

N-[2-Nitro-4-(trifluoromethyl)phenyl]morpholine, 500g

(butan-2-yl)[(2E)-2-(phenylmethylidene)heptyl]amine hydrochloride, 95.0%, 1g

2-Amino-4-(methylselanyl)butanoic acid, 95.0%, 250mg

(Bromomethyl)chlorodimethylsilane>95.0%(GC)5g

1-[2-(1H-1,2,4-triazol-1-yl)ethyl]piperazine trihydrochloride hydrate, 95.0%, 10g

(3-Chloro-4-(methoxycarbonyl)phenyl)boronic acid, 95.0%, 5g

(1S)-1-(2-anthryl)propylamine, 95%, 100mg

2-Bromo-4-fluorobenzoic acid, 97.0%, 50g

Pyromellitic diimide, 97.0%, 10g

Methyl-beta-cyclodextrin, min. 98 %, 5 g, Glasverpackung